Loading...
XNASPRVA
Market cap2.51bUSD
Jan 08, Last price  
21.06USD
1D
3.10%
1Q
22.25%
IPO
-42.37%
Name

Privia Health Group Inc

Chart & Performance

D1W1MN
XNAS:PRVA chart
P/E
109.50
P/S
1.52
EPS
0.19
Div Yield, %
0.00%
Shrs. gr., 5y
3.94%
Rev. gr., 5y
20.31%
Revenues
1.66b
+22.19%
657,609,000786,360,000817,075,000966,220,0001,356,660,0001,657,737,000
Net income
23m
P
-3,044,0008,244,00031,244,000-190,649,000-12,064,00023,079,000
CFO
81m
+71.17%
5,249,00024,358,00038,891,00055,058,00047,196,00080,785,000
Earnings
Feb 25, 2025

Profile

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.
IPO date
Apr 29, 2021
Employees
964
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
1,657,737
22.19%
1,356,660
40.41%
Cost of revenue
1,630,555
1,371,211
Unusual Expense (Income)
NOPBT
27,182
(14,551)
NOPBT Margin
1.64%
Operating Taxes
7,993
(6,516)
Tax Rate
29.41%
NOPAT
19,189
(8,035)
Net income
23,079
-291.30%
(12,064)
-93.67%
Dividends
Dividend yield
Proceeds from repurchase of equity
8,740
13,448
BB yield
-0.30%
-0.53%
Debt
Debt current
6,086
3,013
Long-term debt
13,535
19,993
Deferred revenue
(11,497)
Other long-term liabilities
313
1,000
Net debt
(369,890)
(324,986)
Cash flow
Cash from operating activities
80,785
47,196
CAPEX
(113)
(104)
Cash from investing activities
(42,971)
(104)
Cash from financing activities
3,705
(19,677)
FCF
21,727
(5,374)
Balance
Cash
389,511
347,992
Long term investments
Excess cash
306,624
280,159
Stockholders' equity
(146,480)
(195,590)
Invested Capital
765,514
715,645
ROIC
2.59%
ROCE
4.39%
EV
Common stock shares outstanding
124,686
110,695
Price
23.03
1.41%
22.71
-12.21%
Market cap
2,871,520
14.23%
2,513,889
-9.89%
EV
2,547,582
2,208,858
EBITDA
33,715
(9,980)
EV/EBITDA
75.56
Interest
542
Interest/NOPBT